CBD AND BIPOLAR DISORDER

Cannabis and Mood Disorders.
Lucatch AM, Coles AS, Hill KP, George TP.
Curr Addict Rep. 2018 Sep;5(3):336-345. doi: 10.1007/s40429-018-0214-y. Epub 2018 May 10.
PMID:30643708
Free PMC Article

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Crippa JA, Guimarães FS, Campos AC, Zuardi AW.
Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Review.
PMID:30298064
Free PMC Article

Is there a role for cannabidiol in psychiatry?
Khoury JM, Neves MCLD, Roque MAV, Queiroz DAB, Corrêa de Freitas AA, de Fátima Â, Moreira FA, Garcia FD.
World J Biol Psychiatry. 2019 Feb;20(2):101-116. doi: 10.1080/15622975.2017.1285049. Epub 2017 Feb 20.
PMID:28112021

A developmental study on the neural circuitry mediating response flexibility in bipolar disorder.
Weathers J, Brotman MA, Deveney CM, Kim P, Zarate C Jr, Fromm S, Pine D, Leibenluft E.
Psychiatry Res. 2013 Oct 30;214(1):56-65. doi: 10.1016/j.pscychresns.2013.05.002. Epub 2013 Aug 17. PMID:23958598
Free PMC Article

Cannabidiol in humans-the quest for therapeutic targets.
Zhornitsky S, Potvin S.
Pharmaceuticals (Basel). 2012 May 21;5(5):529-52. doi: 10.3390/ph5050529.
PMID:24281562
Free PMC Article

Endocannabinoid system dysfunction in mood and related disorders.
Ashton CH, Moore PB.
Acta Psychiatr Scand. 2011 Oct;124(4):250-61. doi: 10.1111/j.1600-0447.2011.01687.x. Epub 2011 Mar 9. Review.
PMID:21916860

Cannabidiol was ineffective for manic episode of bipolar affective disorder.
Zuardi A, Crippa J, Dursun S, Morais S, Vilela J, Sanches R, Hallak J.
J Psychopharmacol. 2010 Jan;24(1):135-7. doi: 10.1177/0269881108096521. Epub 2008 Sep 18.
PMID:18801823

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS.
Braz J Med Biol Res. 2006 Apr;39(4):421-9. Epub 2006 Apr 3. Review.
PMID:16612464
Free Article

Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential.
Ashton CH, Moore PB, Gallagher P, Young AH.
J Psychopharmacol. 2005 May;19(3):293-300. Review.
PMID:15888515